Results for tag: "Enstilar"

Enstilar is a topical foam medication used to treat plaque psoriasis. It is a combination of two active ingredients, calcipotriol and betamethasone dipropionate, which work together to reduce inflammation and itching. The foam is applied directly to the affected area and is absorbed quickly into the skin. Enstilar is a relatively new drug on the market, having been approved by the FDA in 2015. Enstilar is part of a larger market of psoriasis drugs, which includes topical creams, ointments, and injections. These drugs are used to reduce the symptoms of psoriasis, such as redness, itching, and scaling. They can also help to reduce the risk of developing psoriatic arthritis. The Enstilar market is highly competitive, with many companies offering similar products. Some of the companies in the market include LEO Pharma, Novartis, and Sun Pharmaceuticals. Show Less Read more